See more : Schindler Holding AG (0QO1.L) Income Statement Analysis – Financial Results
Complete financial analysis of Jushi Holdings Inc. (JUSHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jushi Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Alpen Co.,Ltd. (3028.T) Income Statement Analysis – Financial Results
- Goa Carbon Limited (GOACARBON.BO) Income Statement Analysis – Financial Results
- Choil Aluminum Co., Ltd. (018470.KS) Income Statement Analysis – Financial Results
- Minehub Technologies Inc. (MHUBF) Income Statement Analysis – Financial Results
- B & A Packaging India Limited (BAPACK.BO) Income Statement Analysis – Financial Results
Jushi Holdings Inc. (JUSHF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jushico.com
About Jushi Holdings Inc.
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabidiol supplements, tinctures, capsules, softgels, and topicals under The Bank, The Lab, Nira+ Medicinals, Seche, Tasteology, and Nira brands. As of June 6, 2022, it operated 33 BEYOND/HELLO retail locations. The company was incorporated in 2007 and is headquartered in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 269.45M | 284.28M | 209.29M | 80.77M | 10.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 153.22M | 188.81M | 121.92M | 37.70M | 5.41M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 116.23M | 95.48M | 87.37M | 43.07M | 4.82M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 43.14% | 33.59% | 41.75% | 53.32% | 47.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 156.17M | 101.69M | 46.42M | 33.33M | 127.15K | 80.36K | 315.63K | 914.63K | 1.23M | 1.42M | 3.04M | 1.75M | 26.77K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.96K | 0.00 | 113.04K | 194.52K | 165.85K | 228.23K | 0.00 | 0.00 |
| SG&A | 110.47M | 156.17M | 101.69M | 46.42M | 33.33M | 127.15K | 80.36K | 336.59K | 914.63K | 1.23M | 1.42M | 3.21M | 1.98M | 26.77K | 37.12K |
| Other Expenses | 8.57M | -482.00K | 6.84M | 5.07M | 2.16M | 0.00 | 0.00 | 1.17K | 37.70K | 279.10K | 134.92K | 155.94K | 30.32K | 0.00 | 0.00 |
| Operating Expenses | 119.05M | 156.17M | 108.53M | 51.49M | 35.50M | 127.15K | 80.36K | 337.76K | 952.32K | 1.51M | 1.55M | 3.36M | 2.01M | 26.77K | 37.12K |
| Cost & Expenses | 272.26M | 344.97M | 230.45M | 89.19M | 40.90M | 127.15K | 80.36K | 337.76K | 952.32K | 1.51M | 1.55M | 3.36M | 2.01M | 26.77K | 37.12K |
| Interest Income | 0.00 | 142.00K | 243.00K | 231.00K | 378.49K | 1.07M | 0.00 | 1.70K | 12.51K | 28.83K | 51.43K | 92.24K | 0.00 | 156.00 | 0.00 |
| Interest Expense | -36.97M | 45.73M | 31.20M | 19.13M | 3.25M | 0.00 | 0.00 | 1.70K | 12.51K | 28.83K | 51.43K | 92.24K | 2.66K | 156.00 | -37.12K |
| Depreciation & Amortization | 27.08M | 26.49M | 8.41M | 4.43M | 2.23M | -15.37K | 7.72K | -3.40M | 15.12K | 17.26K | 14.79K | 18.46K | 11.69K | -156.00 | 0.00 |
| EBITDA | 30.91M | -121.65M | -10.89M | -7.10M | -38.64M | -142.51K | -72.64K | -3.74M | -944.29K | -1.50M | -1.50M | -3.31M | -2.00M | -26.77K | -37.12K |
| EBITDA Ratio | 11.47% | -12.15% | -5.20% | -8.79% | -239.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -2.82M | -60.69M | -20.36M | -8.42M | -30.67M | -127.15K | -80.36K | -337.76K | -952.32K | -1.50M | -1.58M | -3.40M | -2.01M | -26.62K | -37.12K |
| Operating Income Ratio | -1.05% | -21.35% | -9.73% | -10.43% | -299.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -31.09M | -113.34M | 88.22M | -185.34M | 7.89M | 15.37K | 7.72K | -3.40M | 19.60K | 28.83K | 48.10K | 92.24K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -33.91M | -193.88M | 52.45M | -201.47M | -26.26M | -111.78K | -72.64K | -3.74M | -932.72K | -1.47M | -1.53M | -3.31M | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -12.58% | -68.20% | 25.06% | -249.42% | -256.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 32.39M | 8.45M | 31.09M | 10.40M | 4.51M | -15.37K | -7.72K | 3.40M | -39.20K | -75.87K | -33.58K | -115.26K | -5.31K | -312.00 | 37.12K |
| Net Income | -66.30M | -202.32M | 20.25M | -211.87M | -30.77M | -111.78K | -64.92K | -7.14M | -932.72K | -1.47M | -1.53M | -3.31M | -2.01M | -26.62K | -37.12K |
| Net Income Ratio | -24.60% | -71.17% | 9.68% | -262.30% | -300.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.34 | -1.06 | 0.12 | -2.13 | -0.37 | -0.05 | -0.03 | -2.97 | -0.39 | -0.61 | -0.64 | -1.37 | -1.08 | -0.40 | -0.68 |
| EPS Diluted | -0.34 | -0.99 | -0.41 | -2.13 | -0.37 | -0.05 | -0.03 | -2.97 | -0.39 | -0.61 | -0.64 | -1.37 | -1.08 | -0.40 | -0.68 |
| Weighted Avg Shares Out | 194.77M | 190.02M | 170.29M | 99.56M | 82.06M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 1.85M | 66.67K | 54.96K |
| Weighted Avg Shares Out (Dil) | 194.77M | 204.24M | 201.61M | 99.56M | 82.06M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 1.85M | 66.67K | 54.96K |
HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain
The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many questions remain.
Marijuana Penny Stocks for September Investment Watchlist
As the cannabis industry grows rapidly, investors are looking for top marijuana penny stocks set for growth. With September fast coming, these possible jewels deserve special attention. The industry's expected expansion, supported by solid facts, fuels hope for significant rewards.
Finding The Long-Term Winners In The Cannabis Sector, August 2023 Update
I will attempt to assess and rank the relative growth potential of the separate competitors in the industry. The industry faces multiple catalysts and is trading near 52-week lows. The cannabis ETFs are full of cash burning companies, so I...
Jushi Holdings opens sixth Beyond Hello dispensary in Woodbridge, Virginia
Jushi Holdings Inc (CSE:JUSH, OTCQX:JUSHF) has announced the opening of its sixth medical cannabis dispensary in Virginia. The vertically integrated, multi-state cannabis operator said Beyond Hello Woodbridge is located in Prince William County in a suburban community just outside of Washington,...
Jushi Holdings Inc. Opens Sixth Beyond Hello™ Dispensary in Woodbridge, Virginia
A Media Snippet accompanying this announcement is available by clicking the image or link above.
The Best List Of Marijuana Stocks In The Sector Today
Marijuana stock investors are continuously looking for new opportunities. Well luckily for them the cannabis industry is still fairly young and new investment opportunities may soon happen. As the sector continues to grow also comes new companies and the ability...
The Best 3 Marijuana Stocks You Need To Know About
What is keeping marijuana stock investors in the game? Well as most would agree it is not like short-term gains. Now at one point in time, marijuana stocks were seen as solid short-term investments for quick turnarounds. Yet with all...
Marijuana Stocks To Watch Before The New Week
Marijuana stocks and the cannabis industry as a whole have seen tremendous growth. This ranges from more states and global regions legalizing cannabis. To companies flourishing through new products and strategic partnerships and collaborations. All of which could create better...
Jushi Holdings Inc. (JUSHF) Q2 2023 Earnings Call Transcript
Jushi Holdings Inc. (OTCQX:JUSHF) Q2 2023 Earnings Conference Call August 11, 2023 8:00 AM ET Company Participants Lisa Forman - Director, Investor Relations Jim Cacioppo - Chairman and Chief Executive Officer Michelle Mosier - Chief Financial Officer Conference Call Participants...
Unveiling the Top US Marijuana Stocks of Q2 2023 Amid Earnings Season
In the dynamic landscape of the US cannabis industry, where the tide of legality has turned in favor of marijuana, investors find themselves at a pivotal juncture. As the cannabis sector readies to disclose its second-quarter earnings in 2023, the...
Source: https://incomestatements.info
Category: Stock Reports